Histologic Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study

PURPOSE: Urinary tract cancer can be pure urothelial carcinoma (PUC), pure non-UC, or variant UC (VUC, defined here as mixed UC). Little is known regarding outcomes for patients with VUC receiving immune checkpoint inhibitors (ICI). We hypothesized that VUC does not compromise ICI efficacy in patien...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Urol
Main Authors: Miller, Natalie J, Khaki, Ali Raza, Diamantopoulos, Leonidas N, Bilen, Mehmet A, Santos, Victor, Agarwal, Neeraj, Morales-Barrera, Rafael, Devitt, Michael, Nelson, Ariel, Hoimes, Christopher J, Shreck, Evan, Assi, Hussein, Gartrell, Benjamin A, Sankin, Alex, Rodriguez-Vida, Alejo, Lythgoe, Mark, Pinato, David J, Drakaki, Alexandra, Joshi, Monika, Isaacsson Velho, Pedro, Hahn, Noah, Liu, Sandy, Alonso Buznego, Lucia, Duran, Ignacio, Moses, Marcus, Jain, Jayanshu, Murgic, Jure, Barata, Pedro, Tripathi, Abhishek, Zakharia, Yousef, Galsky, Matthew D, Sonpavde, Guru, Yu, Evan Y, Lyman, Gary H, Grivas, Petros
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7289665/
https://ncbi.nlm.nih.gov/pubmed/31971495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000000761
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki